Marc Ferrante
Impact in
- Genetics top 10%
- Inflammatory Bowel Disease
-
- Advanced Glycation End Products research
Papers in
- Genetics 9
- Inflammatory Bowel Disease 9
-
- Advanced Glycation End Products research 1
- Co-authors
- Roman Vangoitsenhoven (1 shared paper)Christophe Matthys (1 shared paper)Kristin Verbeke (1 shared paper)João Pedro Guedelha Sabino (1 shared paper)Judith Wellens (1 shared paper)Muriel Derrien (1 shared paper)Bram Verstockt (2 shared papers)Jeroen Raes (1 shared paper)
In The Last Decade
Marc Ferrante
10 papers receiving 228 citations
Marc Ferrante's Hit Papers
Peers
Comparison fields: 5 of 23
- Genetics 209
- Clinical Biochemistry 3
- Immunology 12
- Gastroenterology 2
- Rheumatology 2
Countries citing papers authored by Marc Ferrante
This map shows the geographic impact of Marc Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Ferrante more than expected).
Fields of papers citing papers by Marc Ferrante
This network shows the impact of papers produced by Marc Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Ferrante. The network helps show where Marc Ferrante may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Ferrante, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease Hit paper breakdown → | 2024 | 110 |
| 2 | Risankizumab for Ulcerative Colitis Hit paper breakdown → | 2024 | 80 |
| 3 | 2023 | 23 | |
| 4 | 2025 | 10 | |
| 5 | 2019 | 9 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2016 | 1 |
About Marc Ferrante
Marc Ferrante is a scholar working on Genetics, Clinical Biochemistry, Immunology, Radiology, Nuclear Medicine and Imaging and Nuclear Energy and Engineering, having authored 10 papers that have together received 241 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (9 papers), Biosimilars and Bioanalytical Methods (1 paper), Advanced Glycation End Products research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Genetics (209 citations), Clinical Biochemistry (3 citations), Immunology (12 citations), Gastroenterology (2 citations) and Rheumatology (2 citations). Marc Ferrante has collaborated with scholars based in Belgium, France and Canada. Frequent co-authors include Roman Vangoitsenhoven, Christophe Matthys, Kristin Verbeke, João Pedro Guedelha Sabino, Judith Wellens, Muriel Derrien, Bram Verstockt, Jeroen Raes, Severine A.R.A. Vermeire and Jasmina Kalabic. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, The American Journal of Gastroenterology, JAMA and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.